Skip to content

Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure

Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure Without Known Cardio Vascular or Renal Disease, Stratified on Blood Pressure Control.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00925470
Acronym
PREVENTA
Enrollment
1200
Registered
2009-06-22
Start date
2009-06-30
Completion date
2009-12-31
Last updated
2009-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

Target organs impairment, High blood pressure, Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease

Brief summary

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Design outcomes

Primary

MeasureTime frame
To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)Once

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026